LDL-C (mmol/L) | 2.27 (1.93, 3.06) | 2.39 (2.07, 3.24) | −1.35 | 0.49 |
SUA (mmol/L) | 305.96 (262.71, 385.35) | 296.19 (247.74, 349.26) | −1.41 | 0.16 |
LPa (mmol/L) | 214.6 (101.59, 389.06) | 210.41 (133.78, 330.77) | −0.26 | 0.80 |
HbA1c (%) | 6.15 (5.6, 6.8) | 6.1 (5.7, 6.9) | −0.63 | 0.53 |
药物使用(%) |
|
|
|
|
ACEI/ARB(例) | 34 (25%) | 16 (15.5%) | 3.18 | 0.08 |
ACEI+利尿剂(例) | 38 (27.9%) | 32 (31.1%) | 0.28 | 0.60 |
抗血小板药物 | 110 (80.9%) | 76 (73.8%) | 1.71 | 0.19 |
他汀类药物(例) | 115 (84.6%) | 89 (86.4%) | 0.16 | 0.69 |
二甲双胍(例) | 28 (20.6%) | 25 (24.3%) | 0.46 | 0.49 |
SGLT-2i (例) | 1 (0.8%) | 2 (1.9%) | 0.59 | 0.44 |
DPP-4i (例) | 7 (5.3%) | 3 (2.9%) | 0.91 | 0.34 |
阿卡波糖(例) | 15 (11%) | 14 (3.6%) | 0.36 | 0.55 |
HRV时域指标 |
|
|
|
|
SDNN (ms) | 113.71 ± 30.67 | 118,59 ± 32.25 | −1.19 | 0.24 |
SDANN (ms) | 105.43 ± 30.72 | 112.03 ± 35.01 | −1.55 | 0.12 |
SDNN index (ms) | 42.64 ± 12.95 | 45.02 ± 11.84 | −1.46 | 0.15 |
RMSSD (ms) | 29.99 ± 10.58 | 31.75 ± 10.08 | −1.46 | 0.15 |
PNN50 (%) | 6 (3, 10.75) | 7 (4, 12) | −1.68 | 0.09 |
HRV频域指标 |
|
|
|
|
HF (ms) | 124.4 (73.35, 190.48) | 138.5 (89.3, 198.9) | −1.21 | 0.23 |
LF (ms) | 191.75 (110.1, 294.93) | 221.7 (126.4, 311) | −1.79 | 0.07 |
LF/HF | 1.46 (1.12, 1.94) | 1.59 (1.05, 2.06) | −0.92 | 0.36 |